Andrew Whitehair, a CPA at Baker Tilly, serves a national clientele of tech bros with mega capital gains. His advice: Don't get too technical with your tax maneuvers. What to do if much of your wealth ...

We are exiting our position in Bristol Myers Squibb , selling 1,100 shares at roughly $58.94. In addition, we are initiating a new position in Johnson & Johnson , buying 150 shares at roughly $237.65.

Fundstrat’s Tom Lee believes the stock market (SP500), (COMP:IND), (DJI) is currently in a stronger position than when it reached all-time highs earlier this year, projecting the S&P 500 (SP500) can ...

CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. Growing sales of Casgevy plus new candidates ...

Fundstrat’s Tom Lee joins 'Closing Bell' to discuss what to expect from equity markets going forward, the international market compared to domestic and much more. Got a confidential news tip? We want ...

The war in Iran caused sell-offs for SoFi stock and the broader market in March. A short report targeting the company also caused sell-offs. SoFi stock has seen some recovery in April. SoFi stock saw ...

Zscaler (ZS) was downgraded by BTIG from Buy to Neutral with its price target removed entirely, reflecting a valuation reset rather than fundamental weakness as the stock has fallen sharply despite ...

CRISPR Therapeutics is the second largest holding in Cathie Wood's Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year. These 10 stocks could mint the next wave of ...

It has been nearly three years since I last looked at Energous (WATT). I had covered it for years before that, but the story was fairly similar throughout. Hype (such as rumors of an Apple partnership ...

Alabama football had multiple reasons for optimism during its A-Day scrimmage, including most of its defense, quarterback Keelon Russell and multiple wide receivers. However, on offense, two hugely ...